Send a Message

REFS:

1. Preliminary evaluation of the soothing power of two cosmetic products through a clinical- instrumental test. DKQ-F-003 and DKQ-F-007 – Report No. 1201L19F. November 2012. Data on file. 2.Mwangi H M, Van Der Westhuizen J, Marnewick J, Mabusela W T, Mwadham M K and Ebenso E E. Isolation, identificaion and radical scavenging activity of phlorotannin derivatives from brown algae, Ecklonia maxima: An experimental and theoretical study. Free Radicals and Antioxidants 3 (2013) S1-S10. 3. Evaluation of the possible irritant power of a cosmetic product according to the amended Draize classification. Patch test DQK-F-003 Record No. 1201G06. Data on file.4. Iwamoto K, Hiragun T, Takahagi S, Yanase Y, Mihara S, Kameyoshi Y, Hide M. Fucoidan suppresses IgE production in peripheral blood mononuclear cells from parents with atopic dermatitis. Archives of Dermatological Research, 2011. 303(6):425-31. 5. Thomas N V, Kim S. Potential pharmacological applications of polyphenolic derivatives from marine brown algae. Environmental Toxicology and Pharmacology 32 (2011)325-335. 6. Myers SP, O’Connor J, Ficon JH, Brooks L, Rolfe M, Connellan P, et al. A combined Phase I and II open- label study on the immunomodulatory effects of seaweed extract nutrient complex. Biologics. 2011;5:45-60. 7. Synytsya A, Bleha R, Synytsya A, Pohl R, Hayashi K, Yoshinaga K, et al. Mekabu fucoidan: Structural complexity and defensive effects against avian influenza A viruses. Carbohydr Polym. 2014;111:633-44. 7. Hayashi T, Hayashi K, Kanekiyo K, Ohta Y, Lee J-B. Promising an/viral Glyco-molecules from an edible alga. In: Torrence PF, editor. Comba/ng the Threat of Pandemic Influenza: Drug Discovery Approaches,. Hoboken, New Jersey: John Wiley & Sons; 2007. p. 166-82.